Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Br J Ophthalmol ; 108(2): 294-300, 2024 01 29.
Artículo en Inglés | MEDLINE | ID: mdl-36627174

RESUMEN

BACKGROUND: Graves' orbitopathy (GO) is subject to epidemiological and care-related changes. Aim of the survey was to identify trends in presentation of GO to the European Group On Graves' Orbitopathy (EUGOGO) tertiary referral centres and initial management over time. METHODS: Prospective observational multicentre study. All new referrals with diagnosis of GO within September-December 2019 were included. Clinical and demographic characteristics, referral timelines and initial therapeutic decisions were recorded. Data were compared with a similar EUGOGO survey performed in 2012. RESULTS: Besides age (mean age: 50.5±13 years vs 47.7±14 years; p 0.007), demographic characteristics of 432 patients studied in 2019 were similar to those in 2012. In 2019, there was a decrease of severe cases (9.8% vs 14.9; p<0.001), but no significant change in proportion of active cases (41.3% vs 36.6%; p 0.217). After first diagnosis of GO, median referral time to an EUGOGO tertiary centre was shorter (2 (0-350) vs 6 (0-552) months; p<0.001) in 2019. At the time of first visit, more patients were already on antithyroid medications (80.2% vs 45.0%; p<0.001) or selenium (22.3% vs 3.0%; p<0.001). In 2019, the initial management plans for GO were similar to 2012, except for lid surgery (2.4% vs 13.9%; p<0.001) and prescription of selenium (28.5% vs 21.0%; p 0.027). CONCLUSION: GO patients are referred to tertiary EUGOGO centres in a less severe stage of the disease than before. We speculate that this might be linked to a broader awareness of the disease and faster and adequate delivered treatment.


Asunto(s)
Oftalmopatía de Graves , Selenio , Humanos , Adulto , Persona de Mediana Edad , Oftalmopatía de Graves/diagnóstico , Oftalmopatía de Graves/epidemiología , Oftalmopatía de Graves/terapia , Estudios Prospectivos , Derivación y Consulta , Centros de Atención Terciaria
2.
EMBO J ; 42(18): e111807, 2023 09 18.
Artículo en Inglés | MEDLINE | ID: mdl-37606072

RESUMEN

Cilia are important cellular organelles for signaling and motility and are constructed via intraflagellar transport (IFT). RabL2 is a small GTPase that localizes to the basal body of cilia via an interaction with the centriolar protein CEP19 before downstream association with the IFT machinery, which is followed by initiation of IFT. We reconstituted and purified RabL2 with CEP19 or IFT proteins to show that a reconstituted pentameric IFT complex containing IFT81/74 enhances the GTP hydrolysis rate of RabL2. The binding site on IFT81/74 that promotes GTP hydrolysis in RabL2 was mapped to a 70-amino-acid-long coiled-coil region of IFT81/74. We present structural models for RabL2-containing IFT complexes that we validate in vitro and in cellulo and demonstrate that Chlamydomonas IFT81/74 enhances GTP hydrolysis of human RabL2, suggesting an ancient evolutionarily conserved activity. Our results provide an architectural understanding of how RabL2 is incorporated into the IFT complex and a molecular rationale for why RabL2 dissociates from anterograde IFT trains soon after departure from the ciliary base.


Asunto(s)
Proteínas Activadoras de GTPasa , Transducción de Señal , Humanos , Proteínas Activadoras de GTPasa/genética , Transporte Biológico , Aminoácidos , Guanosina Trifosfato , Proteínas Musculares , Proteínas del Citoesqueleto
3.
Vaccines (Basel) ; 10(12)2022 Nov 25.
Artículo en Inglés | MEDLINE | ID: mdl-36560425

RESUMEN

The World Health Organization (WHO) identified vaccine hesitancy as one of the top 10 threats to global health in 2019. Health promotion and education have been seen to improve knowledge and uptake of vaccinations in pregnancy. This qualitative study was conducted based on phenomenology, a methodological approach to understand first-hand experiences, and grounded theory, an inductive approach to analyse data, where theoretical generalisations emerge. Data were collected through semi-structured interviews with pregnant women attending antenatal care services and healthcare workers (HCWs) in Barcelona, Spain. Interviews were audio-recorded, transcribed, and coded, and notes were taken. Inductive thematic analysis was performed, and data were manually coded. Pertussis was reported as the most trusted vaccine among pregnant women due to its long-standing background as a recommended vaccine in pregnancy. The influenza vaccine was regarded as less important since it was perceived to cause mild disease. The COVID-19 vaccine was the least trustworthy for pregnant women due to uncertainties about effectiveness, health effects in the mid- and long-term, the fast development of the vaccine mRNA technology, and the perceptions of limited data on vaccine safety. However, the necessity to be vaccinated was justified by pregnant women due to the exceptional circumstances of the COVID-19 pandemic. The recommendations provided by HCW and the established relationship between the HCW, particularly midwives, and pregnant women were the main factors affecting decision-making. The role of mass media was perceived as key to helping provide reliable messages about the need for vaccines during pregnancy. Overall, vaccines administered during pregnancy were perceived as great tools associated with better health and improved quality of life. Pregnancy was envisioned as a vulnerable period in women's lives that required risk-benefits assessments for decision-making about maternal vaccinations. A holistic approach involving the community and society was considered crucial for health education regarding maternal vaccines in support of the work conducted by HCWs.

4.
Arch Public Health ; 78: 78, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32944237

RESUMEN

BACKGROUND: During the last decade, the European Union initiated several projects in the domains of public and environmental health. Within this framework, BRIDGE Health (Bridging Information and Data Generation for Evidence-based Health policy and Research) and HBM4EU (European human biomonitoring initiative) have been implemented. Whereas, the focus of BRIDGE Health was towards a sustainable and integrated health information system (HIS), the aim of HBM4EU is to improve evidence of the internal exposure of European citizens to environmental chemicals by human biomonitoring (HBM) and the impact of internal exposure on health. As both, environmental and public health determinants are important for health promotion, disease prevention and policy, BRIDGE Health and HBM4EU have overlapping aims and outcomes. In order to improve health information regarding public health and environmental health issues, best use and exchange of respective networks and project results is necessary. METHODS: Both projects have implemented health information (HI) and HBM tasks in order to provide adequate environmental and public health information of the European population. Synergies of the projects were identified in the working progress and because of overlapping networks and experts a focused analysis of both projects was envisaged. This paper elaborates on the aims and outcomes of both projects and the benefit of merging and channelling research results for the use of better health information and policy making that may be of relevance for any other project in these research fields. RESULTS: The need for focused exchanges and collaborations between the projects were identified and benefits of exchanges were highlighted for the specific areas of indicator development, linkage of data repositories and the combination of HBM studies and health examination surveys (HES). Further recommendations for a European wide harmonisation among different tasks in the fields of public health and environmental health are being developed. CONCLUSIONS: Lessons learned from HBM4EU and BRIDGE Health show that continuous efforts must be undertaken, also by succeeding projects, to guarantee the exchange between public health and environmental health issues. Networks covering both are essential to provide better evidence of knowledge. The experiences from BRIDGE Health and HBM4EU give a valuable input for any future activity in these domains. Avoiding overlaps and streamlining further exchange of public health and environmental health contributes to best use of research results and allows to develop new strategies and tools for improvement of health information and thus enhances people's health and well-being.

5.
BMC Geriatr ; 19(1): 86, 2019 03 18.
Artículo en Inglés | MEDLINE | ID: mdl-30885132

RESUMEN

BACKGROUND: Dozens of scales and questionnaires have been used in the detection of frailty; however, a generalized method for its screening and diagnosis is still lacking in clinical settings. FRAILTOOLS´ main objective is to evaluate the usefulness of frailty scales in the detection of frailty in different clinical and social settings, and its integration in management algorithms for the frail older patient. METHODS: FRAILTOOLS is an observational, longitudinal and prospective study with a follow-up of 6, 12 and 18 months. People older than 75 years old will be recruited from three separate clinical settings (acute geriatric wards, geriatric outpatient clinics and primary care) and one social setting (nursing homes). Exclusion criteria include Mini-mental State Examination < 20 points, and a Barthel index < 90 points, except in nursing home residents (< 40 points). The participants will be recruited in Spain, Italy, France, United Kingdom and Poland. The total sample size will be of 1.940 subjects, 97 subjects in each clinical setting by center. A personal interview with each participant will take place to register data on comorbidity (Charlson Index), functional (SPPB, Barthel and Lawton indexes), cognitive (MMSE) and frailty status (Fried Phenotype, Frailty Trait Scale - short version, SHARE-FI, 35-Items Rockwood Frailty Index, Clinical Frailty Scale, FRAIL scale and Gérontopôle Frailty Screening Tool) in the baseline visit, month 12 and month 18 visit of follow up. At 6 month a phone call will be made to assess whether there have been falls and to check the vital status. DISCUSSION: Currently, the usefulness of certain assessment tools in social and clinical settings have not been properly assessed, including their ability to predict the individual risk for different adverse outcomes, which is the main interest in daily practice. The FRAILTOOLS project concentrates on providing screening and diagnostic tools for frailty in those settings where its prevalence is the highest and where efforts in prevention could make a significant change in the trend towards disability. TRIAL REGISTRATION: Comprehensive validation of frailty assessment tools in older adults in different clinical and social settings (FRAILTOOLS), NCT02637518 (date of registration: 12/18/2015).


Asunto(s)
Prestación Integrada de Atención de Salud/normas , Anciano Frágil , Fragilidad/diagnóstico , Evaluación Geriátrica , Casas de Salud/normas , Encuestas y Cuestionarios/normas , Accidentes por Caídas/prevención & control , Anciano , Anciano de 80 o más Años , Atención Ambulatoria/métodos , Atención Ambulatoria/normas , Prestación Integrada de Atención de Salud/métodos , Femenino , Estudios de Seguimiento , Fragilidad/epidemiología , Fragilidad/terapia , Evaluación Geriátrica/métodos , Servicios de Salud para Ancianos/normas , Humanos , Estudios Longitudinales , Masculino , Atención Primaria de Salud/métodos , Atención Primaria de Salud/normas , Estudios Prospectivos , Reproducibilidad de los Resultados
6.
Mov Disord Clin Pract ; 5(6): 635-639, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30637285

RESUMEN

BACKGROUND: Disorders related to dysfunction of coenzyme (CoQ10) metabolism, including AarF domain containing kinase 3 gene (ADCK3) mutations, have received attention due to the potential for response to CoQ10 supplementation. METHODS: We describe two new cases of neurological syndromes due to ADCK3 mutations that obtained striking benefit from CoQ10, and a third who did not. We also review 20 cases from the literature in which responses to CoQ10 were documented out of all 38 previously reported cases. RESULTS: Despite the remarkable responses in some cases with ataxia and movement disorders (myoclonus, dystonia, tremor), overall, we were not able to identify variables that predicted response to CoQ10 supplementation. CONCLUSIONS: Based on our experience and data from the literature, we recommend a minimum of 10 mg/kg/day of ubiquinone with titration up to 15 mg/kg/day, maintained at least for 6 months in order to obtain or exclude potential benefit from therapy.

7.
Arch Intern Med ; 172(12): 922-8, 2012 Jun 25.
Artículo en Inglés | MEDLINE | ID: mdl-22732747

RESUMEN

BACKGROUND: The length of hospital stay (LOS) for community-acquired pneumonia (CAP) varies considerably, even though this factor has a major impact on the cost of care. We aimed to determine whether the use of a 3-step critical pathway is safe and effective in reducing duration of intravenous antibiotic therapy and length of stay in hospitalized patients with CAP. METHODS: We randomly assigned 401 adults who required hospitalization for CAP to follow a 3-step critical pathway including early mobilization and use of objective criteria for switching to oral antibiotic therapy and for deciding on hospital discharge or usual care. The primary end point was LOS. Secondary end points were the duration of intravenous antibiotic therapy, adverse drug reactions, need for readmission, overall case-fatality rate, and patients' satisfaction. RESULTS: Median LOS was 3.9 days in the 3-step group and 6.0 days in the usual care group (difference, -2.1 days; 95% CI, -2.7 to -1.7; P < .001). Median duration of intravenous antibiotic therapy was 2.0 days in the 3-step group and 4.0 days in the usual care group (difference, -2.0 days; 95% CI, -2.0 to -1.0; P < .001). More patients assigned to usual care experienced adverse drug reactions (4.5% vs 15.9% [difference, -11.4 percentage points; 95% CI, -17.2 to -5.6 percentage points; P < .001]). No significant differences were observed regarding subsequent readmissions, case fatality rate, and patients' satisfaction with care. CONCLUSIONS: The use of a 3-step critical pathway was safe and effective in reducing the duration of intravenous antibiotic therapy and LOS for CAP and did not adversely affect patient outcomes. Such a strategy will help optimize the process of care of hospitalized patients with CAP, and hospital costs would be reduced. TRIAL REGISTRATION: isrctn.org Identifier: ISRCTN17875607.


Asunto(s)
Antibacterianos/administración & dosificación , Vías Clínicas , Tiempo de Internación/estadística & datos numéricos , Neumonía Bacteriana/tratamiento farmacológico , Administración Oral , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/efectos adversos , Infecciones Comunitarias Adquiridas/tratamiento farmacológico , Ambulación Precoz , Femenino , Humanos , Infusiones Intravenosas , Masculino , Persona de Mediana Edad , Readmisión del Paciente/estadística & datos numéricos , Satisfacción del Paciente , Estudios Prospectivos , Adulto Joven
8.
Rev. cuba. invest. biomed ; 18(1): 49-53, ene.-abr. 1999.
Artículo en Español | CUMED | ID: cum-19435

RESUMEN

De todos es conocido que la salud del hombre es un proceso complejo sustentado sobre la base de un equilibrio entre factores biopsicosociales. Lograr que el hombre se adapte a su medio implica la mantención de la adecuada sincronización de las funciones de los sistemas de su organismo y en caso del surgimiento de un desbalance, esta adaptación depende del restablecimiento de ese equilibrio. Si el desbalance es muy grande, generalmente hay necesidad de acudir a un especialista terapeuta, mientras más traumática sea la lesión, más urgente será acudir tanto a la medicina convencional como a la tradicional. En la enfermedad se afecta tanto el cuerpo como la mente y ante todo debemos aceptarla y cada cual debe tomar la dirección y responsabilidad de su salud. En esta revisión se introduce la psiconeuroinmunología como nueva rama de la medicina, donde se establece la relación entre la mente y el cuerpo. (AU)


Asunto(s)
Psiconeuroinmunología
9.
Rev. cuba. invest. bioméd ; 18(1): 49-53, ene.-abr. 1999.
Artículo en Español | LILACS | ID: lil-302392

RESUMEN

De todos es conocido que la salud del hombre es un proceso complejo sustentado sobre la base de un equilibrio entre factores biopsicosociales. Lograr que el hombre se adapte a su medio implica la mantención de la adecuada sincronización de las funciones de los sistemas de su organismo y en caso del surgimiento de un desbalance, esta adaptación depende del restablecimiento de ese equilibrio. Si el desbalance es muy grande, generalmente hay necesidad de acudir a un especialista terapeuta, mientras más traumática sea la lesión, más urgente será acudir tanto a la medicina convencional como a la tradicional. En la enfermedad se afecta tanto el cuerpo como la mente y ante todo debemos aceptarla y cada cual debe tomar la dirección y responsabilidad de su salud. En esta revisión se introduce la psiconeuroinmunología como nueva rama de la medicina, donde se establece la relación entre la mente y el cuerpo.


Asunto(s)
Psiconeuroinmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA